Prognosticating ovarian reserve by the new ovarian response prediction index

In: International Journal of Reproduction, Contraception, Obstetrics and Gynecology · 2018 · vol. 7(3) , pp. 1196 · doi:10.18203/2320-1770.ijrcog20180917 · W2789882335
OA: diamond CC0
⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-08 · read from full text ⓘ

This study evaluated the predictive accuracy of the Ovarian Response Prediction Index (ORPI) for ovarian reserve in fifty patients undergoing in vitro fertilization cycles. The researchers excluded individuals with severe endometriosis, ovarian surgery history, or endocrine disorders to ensure a cohort focused on standard assisted reproductive technology outcomes. Results demonstrated that ORPI, which combines age, antral follicle count, and anti-Mullerian hormone levels, provided superior prediction of both low and excessive ovarian response compared to any single biomarker alone. Relevance to endometriosis: The paper explicitly excludes patients with severe endometriosis from its study population, indicating it does not directly investigate the condition but rather focuses on general IVF stimulation protocols.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Background: Knowledge of patient's potential ovarian response can help individualise the medication dosage and thus prevent adverse effect of excessive ovarian response and, decrease the rates of cancelled cycles, overall it will help to improve the cost benefit ratio of ovarian stimulation regimes. In addition to age, several clinical, endocrine and USG markers and dynamic tests have been proposed for the prediction of ovarian response to stimulation. Among these use of AMH levels and AFC are of particular interest However, despite the predictive power that each marker for the ovarian response may individually have, all these markers have errors associated with their estimation. So, prediction of ovarian response using a single biomarker may not be sufficient for formulation of a precise treatment plan.Methods: This study includes 50 patients undergoing ivf cycle. All patients satisfied the following criteria; age <or equal to 39 yrs, BMI between 20-30, regular menstrual cycles, both ovaries present, no history of ovarian surgery, no severe endometriosis and no evidence of endocrine disorders. The only exclusion criteria was the presence of ovarian cysts as assessed by TVS.Results: The results showed significant correlation between the number of obtained follicles and the number and maturity of collected oocytes. In addition, the results using the ORPI were always better than those obtained using other predictive factors (AFC, AGE and AMH) separately.Conclusions: The present study reinforces the ORPI, which is a simple 3 variable index that exhibits an excellent ability to predict low and excessive ovarian response. ORPI might be used to improve the cost benefit ratio of ovarian stimulation regimens by guiding the selection of medication and by tailoring the doses and regimens to the actual needs of patients.
Full text 3,348 characters · extracted from oa-doi-fallback · 5 sections · click to expand

Background

Knowledge of patient's potential ovarian response can help individualise the medication dosage and thus prevent adverse effect of excessive ovarian response and, decrease the rates of cancelled cycles, overall it will help to improve the cost benefit ratio of ovarian stimulation regimes. In addition to age, several clinical, endocrine and USG markers and dynamic tests have been proposed for the prediction of ovarian response to stimulation. Among these use of AMH levels and AFC are of particular interest However, despite the predictive power that each marker for the ovarian response may individually have, all these markers have errors associated with their estimation. So, prediction of ovarian response using a single biomarker may not be sufficient for formulation of a precise treatment plan.

Methods

This study includes 50 patients undergoing ivf cycle. All patients satisfied the following criteria; age <or equal to 39 yrs, BMI between 20-30, regular menstrual cycles, both ovaries present, no history of ovarian surgery, no severe endometriosis and no evidence of endocrine disorders. The only exclusion criteria was the presence of ovarian cysts as assessed by TVS.

Results

The results showed significant correlation between the number of obtained follicles and the number and maturity of collected oocytes. In addition, the results using the ORPI were always better than those obtained using other predictive factors (AFC, AGE and AMH) separately.

Conclusions

The present study reinforces the ORPI, which is a simple 3 variable index that exhibits an excellent ability to predict low and excessive ovarian response. ORPI might be used to improve the cost benefit ratio of ovarian stimulation regimens by guiding the selection of medication and by tailoring the doses and regimens to the actual needs of patients. Metrics

References

Makkar G, Ng EH, Yeung WS, Ho PC. Excessive ovarian response is associated with increased expression of interleukin-2 in the periimplantation endometrium. Fertil Steril. 2009 Apr 1;91(4):1145-51. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF out-come. Hum Reprod Update. 2006;12:685-718. Sauer MV, Paulson RJ, Lobo RA. A preliminary report on oocyte donation extending reproductive potential to women over 40. N Engl J Med. 2000;323:1157-60. Peters H, Byskov, AG, Himelstein-Graw, R, Faber M. Follicular growth (the basic event in the mouse and human ovary). J Reprod Fertil. 2000;45:559-66. Muttukrishna S, McGarrigle H, Wakim R, Khadum I, Ranieri DM, Serhal P. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? BJOG. 2005;112:1384-90. Singh M, Malik E. AMH as predictive marker of ovarian response in ART. Human Reprod. 2012;43:56. Aflatoonian A, Oskouian H, Ahmadi S, Oskouian L. Prediction of high ovarian response to controlled ovarian hyperstimulation: anti-Mullerian hormone versus small antral follicle count (2–6 mm). J Assist Reprod Genet. 2009 Jun;26(6):319-25.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (7)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK